Health Care & Life Sciences » Pharmaceuticals | Sage Therapeutics Inc.

Sage Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
8,066.00
127,766.00
186,753.00
397,479.00
518,848.00
922,776
Other Current Assets
341.00
1,056.00
1,738.00
5,100.00
6,227.00
21,919
Total Current Assets
8,407.00
128,822.00
188,491.00
402,579.00
525,075.00
944,695
Net Property, Plant & Equipment
86.00
163.00
286.00
1,388.00
4,013.00
5,643
Total Investments and Advances
39.00
39.00
39.00
564.00
849.00
2,367
Other Assets
-
-
200.00
-
-
-
Total Assets
8,532.00
129,665.00
189,016.00
404,531.00
529,937.00
952,705
Accounts Payable
1,988.00
-
-
-
9,350.00
Income Tax Payable
-
641.00
-
-
-
Other Current Liabilities
327.00
7,116.00
15,307.00
35,169.00
42,601.00
Total Current Liabilities
2,315.00
7,757.00
15,307.00
35,169.00
51,951.00
Deferred Taxes
-
641.00
-
-
-
Other Liabilities
44.00
23.00
14.00
845.00
2,511.00
Total Liabilities
2,359.00
7,780.00
15,321.00
36,014.00
54,462.00
Common Equity (Total)
31,536.00
121,885.00
173,695.00
368,517.00
475,475.00
Total Shareholders' Equity
6,173.00
121,885.00
173,695.00
368,517.00
475,475.00
Total Equity
6,173.00
121,885.00
173,695.00
368,517.00
475,475.00
Liabilities & Shareholders' Equity
8,532.00
129,665.00
189,016.00
404,531.00
529,937.00
Preferred Stock (Carrying Value)
37,709.00
-
-
-
-

About Sage Therapeutics

View Profile
Address
215 First Street
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.sagerx.com
Updated 07/08/2019
SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.